Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.
(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...
Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a ...
Hosted on MSN11d
BTIG Downgrades Inari Medical (NARI)Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.
Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: ...
NEW DELHI, INDIA - ZIMBABWE is one of the few countries in the region without a formal agreement with India for its citizens ...
Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...
Tyler J. Hall pleaded guilty to introducing unapproved drugs into interstate commerce, a violation of federal law that requires FDA approval to sell the chemicals for human consumption.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback